McDonald’s Corp. (NYSE: MCD) Q4 2020 earnings call dated Jan. 28, 2021
Corporate Participants:
Mike Cieplak — Corporate Vice President, Investor Relations Officer
Chris Kempczinski — President and Chief Executive Officer
Kevin Ozan — Executive Vice President and Chief Financial Officer
Analysts:
John Glass — Morgan Stanley — Analyst
Eric Gonzalez — KeyBanc — Analyst
David Tarantino — Baird — Analyst
Dennis Geiger — UBS — Analyst
David Palmer — Evercore — Analyst
Jon Tower — Wells Fargo — Analyst
Chris Carril — RBC — Analyst
Jared Garber — Goldman Sachs — Analyst
John Ivankoe — JPMorgan — Analyst
Andrew Charles — Cowen — Analyst
Jeff Bernstein — Barclays — Analyst
Lauren Silberman — Credit Suisse — Analyst
Greg Francfort — Bank of America Merrill Lynch — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Context Therapeutics: Another clinical-stage oncology research firm to go public soon
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
Listen On
